SlideShare a Scribd company logo
1 of 1
Download to read offline
B
lood glucose monitoring
is a valuable diabetes self-
management tool, which
enables people with diabetes
to check their blood glucose levels as
often as they need to, as recommended
by their healthcare professionals.
Large clinical studies, such as the
Diabetes Control and Complications
Trial1
and the UK Prospective Diabetes
Study2,3
have provided clear evidence
of the benefits of intensive therapy in
people with diabetes, and emphasised
SMBG as an important component,
particularly for those requiring insulin
therapy.
Pushing past the pain barrier
Pain, however, is the number one
barrier to patients regularly testing
their blood glucose levels—Burge
showed that lancing pain and finger
soreness are leading reasons for
self-reported patient noncompliance
with medical recommendations for
SMBG.4
This lack of compliance also
predicted hospitalisation of people
with diabetes.4
A 2008 review5
on practices and
trends in measuring blood glucose
concentrations found: ‘It is finger
pricking that makes SMBG an
annoying procedure; the relative
pain is greater than that of the insulin
injection. Beside costs, this is the
major reason why patients tend not to
measure their BG frequently enough.’
In addition, 30% of respondents
in a 2004 UK study by Batten
indicated that pain was a main factor
that stopped them testing blood
glucose. Thirty-five per cent said they
would test more often if it were less
painful—49% in the case of people
injecting insulin, which can amount to
several times a day.6
Pharmacist role in lancing
education
Correctlancingtechniquehelpstokeep
discomforttoaminimumandreducefinger
lesionsandinjury.7
TheAustralianDiabetes
EducatorsAssociation’s2010Position
StatementonUseofBloodGlucose
Meters8
states:‘Wheremetersaresoldin
pharmaciesandotherretailenvironments,
itisessentialforastaffmemberdeemed
competentintheuseofbloodglucose
metersandtheinterpretationofblood
glucoseresultstoprovideeducationtothe
personpurchasingthemeter.’
• Since the lancet penetrates the skin,
hygiene is very important.
• New, unused Accu-Chek lancets are
guaranteed to be sterile.
• Make sure your customers change to
a new lancet for every blood sample.
You can help your patients test more
comfortably with Accu-Chek Lancing
Devices by demonstrating these five
easy steps, as demonstrated in Figure
One: Tips for correct lancing.
Virtuallypain-freetestingwith
Accu-ChekLancingDevices
Roche Diabetes Care, with 30 years
of commitment to helping people
optimally self-manage their diabetes, has
1716
The Australian journal of Pharmacy vol.93 july 2012
coveradvertorial
The Australian journal of Pharmacy vol.93 july 2012
pioneered new technology to reduce the
pain of lancing and make SMBG easier.
AllAccu-Chekconsumerlancing
devicesfeatureClixmotiontechnologythat
helpspreventvibrationandreducestissue
damageforvirtuallypain-freemonitoring.
Pharmacist feedback
We’re a NDSS sub-agent and have
used the Accu-Chek Multiclix with our
type 1 and type 2 diabetes patients. The
feedback has been good as people like
it: it’s not pain-free but it’s painless in
the sense of less fuss. Most people are
familiar with single-use lancets, which are
a little thicker, but we tell them that this is
thinner and finer, and much less painful
than insulin pens. It’s worth showing
older patients how to change each lancet
and each drum of lancets, as they don’t
always realise there’s six and once you’ve
removed a drum you can’t re-insert it
even if you haven’t used all the lancets. A
proper demonstration reinforced during
the initial learning period, as you would
with an asthma device, can take as long
as showing them how to use a meter.
Nick Hatzisavas
Oze Pharmacy, Richmond NSW
With some of the older patients it’s not
as straightforward as with a single-use
ACCU-CHEK cover advertorial
Lancing is a fundamental step in self-monitoring of blood
glucose (SMBG) for people with diabetes and pharmacists
can make a profound difference in their lives by assisting
customers on tips for correct lancing, choosing the right
lancing device and how often to change the lancet.
Fingers love
Accu-Chek lancets
ACCU-CHEK,ACCU-CHEK PERFORMA,ACCU-CHEK
PERFORMA NANO,ACCU-CHEK MOBILE,ACCU-
CHEK ACTIVE,ACCU-CHEK MULTICLIX,ACCU-CHEK
SOFTCLIX  CIXMOTION are trademarks of
Roche.©
2012 Roche Diagnostics.
All other Trademarks are the property
of their respective owners
Roche Diagnostics Australia Pty Ltd,
31 Victoria Avenue, Castle Hill NSW 2154,
ABN 29 003 001 205
Accu-Chek®
lancing devices are
for single patient use only.
REFERENCES
1. Diabetes Control and Complications Trial
Research Group.The effect of intensive
treatment of diabetes on the development
and progression of long-term complications
in insulin-dependent diabetes mellitus. NEJM.
2002;329:977–86.
2. UK Prospective Diabetes Study Group.
Effect of intensive blood-glucose control with
metformin on complications in overweight
patients with type 2 diabetes (UKPDS 34).
Lancet. 1998;352:854–65.
3. UK Prospective Diabetes Study Group.
Intensive blood-glucose control with
sulphonylureas or insulin compared
with conventional treatment and risk of
complications in patients with type 2 diabetes
(UKPDS 33). Lancet.1998;353:836–53.
4. . Lack of compliance with home blood
glucose monitoring predicts hospitalization in
diabetes. Diabetes Care 2001;24(8):1502–3.
5. Heinemann L. Measuring Glucose
Concentrations: Daily Practice, Current and
Future Developments. J Diabetes Sci Technol
2008;2(4): 710–17.
6. Batten L. Report on research on attitudes
of ‘non-testers’. Prepared for Diabetes UK by
Crossbow Research,August 2004.
7. Kocher S,Tshiang Tshiananga JK, Koubek R.
Comparison of lancing devices for self-
monitoring of blood glucose regarding lancing
pain. J Diabetes Sci Technol 2009;3(5):1136–43.
8.ADEA. Position Statement. Use of Blood
Glucose Meters. March 2010.
*Data on file
ACCU-CHEKcoveradvertorial
FIGURE ONE: Tips for correct lancing
FIGURE two: Accu-Chek Clixmotion technology
Accu-Chek Multiclix
• Skin penetration depth can be set by a comfort dial with 11 depth settings—allowing users to find their
preferred skin penetration depth to minimise pain.
• Drum feature ensures single use—each twist of the Accu-Chek Multiclix will prime a fresh single-use
lancet from the drum of six, guaranteeing each to be optimally sharp and sterile.
• The numbers on the display show how many lancets are left.
• No lancet handling—the lancets are not exposed from the drum while installing or removing it.
• Drums are self-disabling, allowing for easy and safe disposal once empty.
• Suitable for alternative site testing (with Accu-Chek AST cap) if appropriate.
Softclix and some will come to me if
they want me to change drums. Multiclix
is a lot better because the
recommendation
is to use a new
lancet every time
but in practice
we know that’s not
the case—Mutliclix
means there’s less
pain in the first place
because the lancet
is sharp. When we run
diabetes weeks, there’s
quite a number of customers who don’t
realise you have to change lancets and
they end up with calluses. It’s easy to
demonstrate; customers
usually get it first go.
Using newer lancets
more frequently is
always going to be a
good thing and lead
to better control.
I’m type 1 and
I’ve got about
every monitor
but I generally always
choose the Accu-Chek monitor.
Steve Rabe, You Save, Mosman NSW
Experience
what’s
possible.
Enq
uiry Line: 180
0 251
816
Fingers love
Accu-Chek
®
lancets
Who would
ima
gine blood glucos
e monitoring
cou
ld be so gen
tle?
The
Acc
u-Chek
lancing range
uses exclusive Clixmotion
technology to deliver
a
precise
, guided
movem
ent – for virtually pain-free
testing
your fingers will
love
.
Com
es FRE
E inside every Acc
u-Chek
Perform
a
and
Acc
u-Chek
Perform
a Nano meter pack.
Experience
what’s
possible.
Enq
uiry
Line: 180
0 251
816
National Diabetes
Awareness Week 2012
Virtually pain
-free testing in every Accu-Chek
meter pack.*
Love your fingers with
Accu-Chek
®
lancing
Every Accu-Chek meter pack comes with a Clixmotion-guided lancing device
for virtually pain-free monitoring*.

More Related Content

Viewers also liked (10)

Reestratsiya zno-2015
Reestratsiya zno-2015Reestratsiya zno-2015
Reestratsiya zno-2015
 
Locksmi̇th
Locksmi̇thLocksmi̇th
Locksmi̇th
 
Course 2 week 6 lesson 10
Course 2 week 6 lesson 10Course 2 week 6 lesson 10
Course 2 week 6 lesson 10
 
Hexagon to triangle
Hexagon to triangleHexagon to triangle
Hexagon to triangle
 
Mozart effectfull
Mozart effectfullMozart effectfull
Mozart effectfull
 
тартаківська зш
тартаківська зш тартаківська зш
тартаківська зш
 
ANU Phi Delta Lambda Certificate
ANU Phi Delta Lambda CertificateANU Phi Delta Lambda Certificate
ANU Phi Delta Lambda Certificate
 
Blog 2
Blog 2Blog 2
Blog 2
 
Jyothir
JyothirJyothir
Jyothir
 
В дороге
В дорогеВ дороге
В дороге
 

Similar to 16 cover adv-sc

Digestive Health small
Digestive Health smallDigestive Health small
Digestive Health smallVanessa Dodd
 
C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015Diabetes for all
 
Marketing plan for glucometers - product management
Marketing plan for glucometers - product managementMarketing plan for glucometers - product management
Marketing plan for glucometers - product managementDr. Zubair Ali
 
2008 Nice insulin pump quick reference guidelines
2008 Nice insulin pump quick reference guidelines2008 Nice insulin pump quick reference guidelines
2008 Nice insulin pump quick reference guidelinesPeninsulaEndocrine
 
Evidence based practice for nurses, diabetics, and learning institutions
Evidence based practice for nurses, diabetics, and learning institutionsEvidence based practice for nurses, diabetics, and learning institutions
Evidence based practice for nurses, diabetics, and learning institutionsForward Thinking, LLC
 
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdfThe_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdfSaraAspuru3
 
C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...
C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...
C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...Diabetes for all
 
EPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02FebEPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02FebJennifer McCoy
 
C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11Diabetes for all
 
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)DrPravinPatelNevada
 
Capnography: Discover Patient Safety Secrets Right Under Your Nose
Capnography: Discover Patient Safety Secrets Right Under Your NoseCapnography: Discover Patient Safety Secrets Right Under Your Nose
Capnography: Discover Patient Safety Secrets Right Under Your NoseChristina Mason
 
Glycemic elderly study
Glycemic elderly studyGlycemic elderly study
Glycemic elderly studySteve Epstein
 
Management of Diabetic Ketoacidosis DKA 2013 Guidelines.pdf
Management of Diabetic Ketoacidosis DKA 2013 Guidelines.pdfManagement of Diabetic Ketoacidosis DKA 2013 Guidelines.pdf
Management of Diabetic Ketoacidosis DKA 2013 Guidelines.pdfDr Musadiq
 
C12 british diabetes societies management of dka 2013
C12 british diabetes societies management of dka 2013C12 british diabetes societies management of dka 2013
C12 british diabetes societies management of dka 2013Diabetes for all
 
4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptxDESMONDEZIEKE1
 
De-challenge and Rechallenge
De-challenge and RechallengeDe-challenge and Rechallenge
De-challenge and RechallengeClinosolIndia
 
AugurixDiagnostic_public profile
AugurixDiagnostic_public profileAugurixDiagnostic_public profile
AugurixDiagnostic_public profileGino Borrelli
 
Dispepsia guidelines
Dispepsia guidelinesDispepsia guidelines
Dispepsia guidelinesardhiaputri
 

Similar to 16 cover adv-sc (20)

Digestive Health small
Digestive Health smallDigestive Health small
Digestive Health small
 
C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015C1 cda in hospital management of diabetes 2015
C1 cda in hospital management of diabetes 2015
 
Marketing plan for glucometers - product management
Marketing plan for glucometers - product managementMarketing plan for glucometers - product management
Marketing plan for glucometers - product management
 
2008 Nice insulin pump quick reference guidelines
2008 Nice insulin pump quick reference guidelines2008 Nice insulin pump quick reference guidelines
2008 Nice insulin pump quick reference guidelines
 
Evidence based practice for nurses, diabetics, and learning institutions
Evidence based practice for nurses, diabetics, and learning institutionsEvidence based practice for nurses, diabetics, and learning institutions
Evidence based practice for nurses, diabetics, and learning institutions
 
ABBOTT.pptx
ABBOTT.pptxABBOTT.pptx
ABBOTT.pptx
 
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdfThe_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
The_management_of_diabetic_ketoacidosis_in_adults_An_updated_guideline.pdf
 
C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...
C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...
C13 nice allogeneic pancreatic islet cell transplantation for type 1 diabetes...
 
EPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02FebEPIQNewsletter_2016_02Feb
EPIQNewsletter_2016_02Feb
 
C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11C2 aus diabetes management in g practice australia 2010 11
C2 aus diabetes management in g practice australia 2010 11
 
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
Stem Cell Treatment By Dr. Pravin Patel (Vadodara)
 
Capnography: Discover Patient Safety Secrets Right Under Your Nose
Capnography: Discover Patient Safety Secrets Right Under Your NoseCapnography: Discover Patient Safety Secrets Right Under Your Nose
Capnography: Discover Patient Safety Secrets Right Under Your Nose
 
Glycemic elderly study
Glycemic elderly studyGlycemic elderly study
Glycemic elderly study
 
Management of Diabetic Ketoacidosis DKA 2013 Guidelines.pdf
Management of Diabetic Ketoacidosis DKA 2013 Guidelines.pdfManagement of Diabetic Ketoacidosis DKA 2013 Guidelines.pdf
Management of Diabetic Ketoacidosis DKA 2013 Guidelines.pdf
 
C12 british diabetes societies management of dka 2013
C12 british diabetes societies management of dka 2013C12 british diabetes societies management of dka 2013
C12 british diabetes societies management of dka 2013
 
4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx4 Sally Diagnostics UK May 2016 v3.1.pptx
4 Sally Diagnostics UK May 2016 v3.1.pptx
 
De-challenge and Rechallenge
De-challenge and RechallengeDe-challenge and Rechallenge
De-challenge and Rechallenge
 
Sepsis
SepsisSepsis
Sepsis
 
AugurixDiagnostic_public profile
AugurixDiagnostic_public profileAugurixDiagnostic_public profile
AugurixDiagnostic_public profile
 
Dispepsia guidelines
Dispepsia guidelinesDispepsia guidelines
Dispepsia guidelines
 

More from Steven Chong

June issue v3_Pfizer final review-sc
June issue v3_Pfizer final review-scJune issue v3_Pfizer final review-sc
June issue v3_Pfizer final review-scSteven Chong
 
DWD_MEDIA_KIT_2015-digital
DWD_MEDIA_KIT_2015-digitalDWD_MEDIA_KIT_2015-digital
DWD_MEDIA_KIT_2015-digitalSteven Chong
 
Blackmores PUREAnimal Vol4-sc
Blackmores PUREAnimal Vol4-scBlackmores PUREAnimal Vol4-sc
Blackmores PUREAnimal Vol4-scSteven Chong
 
AJP Sept 08_p52-53
AJP Sept 08_p52-53AJP Sept 08_p52-53
AJP Sept 08_p52-53Steven Chong
 

More from Steven Chong (9)

JCM03May
JCM03MayJCM03May
JCM03May
 
PBI masthead
PBI mastheadPBI masthead
PBI masthead
 
June issue v3_Pfizer final review-sc
June issue v3_Pfizer final review-scJune issue v3_Pfizer final review-sc
June issue v3_Pfizer final review-sc
 
03 HHW55 NEW2
03 HHW55 NEW203 HHW55 NEW2
03 HHW55 NEW2
 
DWD_MEDIA_KIT_2015-digital
DWD_MEDIA_KIT_2015-digitalDWD_MEDIA_KIT_2015-digital
DWD_MEDIA_KIT_2015-digital
 
34 AJP JUNE 2010
34 AJP JUNE 201034 AJP JUNE 2010
34 AJP JUNE 2010
 
Blackmores PUREAnimal Vol4-sc
Blackmores PUREAnimal Vol4-scBlackmores PUREAnimal Vol4-sc
Blackmores PUREAnimal Vol4-sc
 
CMCommentFeb
CMCommentFebCMCommentFeb
CMCommentFeb
 
AJP Sept 08_p52-53
AJP Sept 08_p52-53AJP Sept 08_p52-53
AJP Sept 08_p52-53
 

16 cover adv-sc

  • 1. B lood glucose monitoring is a valuable diabetes self- management tool, which enables people with diabetes to check their blood glucose levels as often as they need to, as recommended by their healthcare professionals. Large clinical studies, such as the Diabetes Control and Complications Trial1 and the UK Prospective Diabetes Study2,3 have provided clear evidence of the benefits of intensive therapy in people with diabetes, and emphasised SMBG as an important component, particularly for those requiring insulin therapy. Pushing past the pain barrier Pain, however, is the number one barrier to patients regularly testing their blood glucose levels—Burge showed that lancing pain and finger soreness are leading reasons for self-reported patient noncompliance with medical recommendations for SMBG.4 This lack of compliance also predicted hospitalisation of people with diabetes.4 A 2008 review5 on practices and trends in measuring blood glucose concentrations found: ‘It is finger pricking that makes SMBG an annoying procedure; the relative pain is greater than that of the insulin injection. Beside costs, this is the major reason why patients tend not to measure their BG frequently enough.’ In addition, 30% of respondents in a 2004 UK study by Batten indicated that pain was a main factor that stopped them testing blood glucose. Thirty-five per cent said they would test more often if it were less painful—49% in the case of people injecting insulin, which can amount to several times a day.6 Pharmacist role in lancing education Correctlancingtechniquehelpstokeep discomforttoaminimumandreducefinger lesionsandinjury.7 TheAustralianDiabetes EducatorsAssociation’s2010Position StatementonUseofBloodGlucose Meters8 states:‘Wheremetersaresoldin pharmaciesandotherretailenvironments, itisessentialforastaffmemberdeemed competentintheuseofbloodglucose metersandtheinterpretationofblood glucoseresultstoprovideeducationtothe personpurchasingthemeter.’ • Since the lancet penetrates the skin, hygiene is very important. • New, unused Accu-Chek lancets are guaranteed to be sterile. • Make sure your customers change to a new lancet for every blood sample. You can help your patients test more comfortably with Accu-Chek Lancing Devices by demonstrating these five easy steps, as demonstrated in Figure One: Tips for correct lancing. Virtuallypain-freetestingwith Accu-ChekLancingDevices Roche Diabetes Care, with 30 years of commitment to helping people optimally self-manage their diabetes, has 1716 The Australian journal of Pharmacy vol.93 july 2012 coveradvertorial The Australian journal of Pharmacy vol.93 july 2012 pioneered new technology to reduce the pain of lancing and make SMBG easier. AllAccu-Chekconsumerlancing devicesfeatureClixmotiontechnologythat helpspreventvibrationandreducestissue damageforvirtuallypain-freemonitoring. Pharmacist feedback We’re a NDSS sub-agent and have used the Accu-Chek Multiclix with our type 1 and type 2 diabetes patients. The feedback has been good as people like it: it’s not pain-free but it’s painless in the sense of less fuss. Most people are familiar with single-use lancets, which are a little thicker, but we tell them that this is thinner and finer, and much less painful than insulin pens. It’s worth showing older patients how to change each lancet and each drum of lancets, as they don’t always realise there’s six and once you’ve removed a drum you can’t re-insert it even if you haven’t used all the lancets. A proper demonstration reinforced during the initial learning period, as you would with an asthma device, can take as long as showing them how to use a meter. Nick Hatzisavas Oze Pharmacy, Richmond NSW With some of the older patients it’s not as straightforward as with a single-use ACCU-CHEK cover advertorial Lancing is a fundamental step in self-monitoring of blood glucose (SMBG) for people with diabetes and pharmacists can make a profound difference in their lives by assisting customers on tips for correct lancing, choosing the right lancing device and how often to change the lancet. Fingers love Accu-Chek lancets ACCU-CHEK,ACCU-CHEK PERFORMA,ACCU-CHEK PERFORMA NANO,ACCU-CHEK MOBILE,ACCU- CHEK ACTIVE,ACCU-CHEK MULTICLIX,ACCU-CHEK SOFTCLIX CIXMOTION are trademarks of Roche.© 2012 Roche Diagnostics. All other Trademarks are the property of their respective owners Roche Diagnostics Australia Pty Ltd, 31 Victoria Avenue, Castle Hill NSW 2154, ABN 29 003 001 205 Accu-Chek® lancing devices are for single patient use only. REFERENCES 1. Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM. 2002;329:977–86. 2. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65. 3. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet.1998;353:836–53. 4. . Lack of compliance with home blood glucose monitoring predicts hospitalization in diabetes. Diabetes Care 2001;24(8):1502–3. 5. Heinemann L. Measuring Glucose Concentrations: Daily Practice, Current and Future Developments. J Diabetes Sci Technol 2008;2(4): 710–17. 6. Batten L. Report on research on attitudes of ‘non-testers’. Prepared for Diabetes UK by Crossbow Research,August 2004. 7. Kocher S,Tshiang Tshiananga JK, Koubek R. Comparison of lancing devices for self- monitoring of blood glucose regarding lancing pain. J Diabetes Sci Technol 2009;3(5):1136–43. 8.ADEA. Position Statement. Use of Blood Glucose Meters. March 2010. *Data on file ACCU-CHEKcoveradvertorial FIGURE ONE: Tips for correct lancing FIGURE two: Accu-Chek Clixmotion technology Accu-Chek Multiclix • Skin penetration depth can be set by a comfort dial with 11 depth settings—allowing users to find their preferred skin penetration depth to minimise pain. • Drum feature ensures single use—each twist of the Accu-Chek Multiclix will prime a fresh single-use lancet from the drum of six, guaranteeing each to be optimally sharp and sterile. • The numbers on the display show how many lancets are left. • No lancet handling—the lancets are not exposed from the drum while installing or removing it. • Drums are self-disabling, allowing for easy and safe disposal once empty. • Suitable for alternative site testing (with Accu-Chek AST cap) if appropriate. Softclix and some will come to me if they want me to change drums. Multiclix is a lot better because the recommendation is to use a new lancet every time but in practice we know that’s not the case—Mutliclix means there’s less pain in the first place because the lancet is sharp. When we run diabetes weeks, there’s quite a number of customers who don’t realise you have to change lancets and they end up with calluses. It’s easy to demonstrate; customers usually get it first go. Using newer lancets more frequently is always going to be a good thing and lead to better control. I’m type 1 and I’ve got about every monitor but I generally always choose the Accu-Chek monitor. Steve Rabe, You Save, Mosman NSW Experience what’s possible. Enq uiry Line: 180 0 251 816 Fingers love Accu-Chek ® lancets Who would ima gine blood glucos e monitoring cou ld be so gen tle? The Acc u-Chek lancing range uses exclusive Clixmotion technology to deliver a precise , guided movem ent – for virtually pain-free testing your fingers will love . Com es FRE E inside every Acc u-Chek Perform a and Acc u-Chek Perform a Nano meter pack. Experience what’s possible. Enq uiry Line: 180 0 251 816 National Diabetes Awareness Week 2012 Virtually pain -free testing in every Accu-Chek meter pack.* Love your fingers with Accu-Chek ® lancing Every Accu-Chek meter pack comes with a Clixmotion-guided lancing device for virtually pain-free monitoring*.